Reduction in Acute Filariasis Morbidity during a Mass Drug Administration Trial to Eliminate Lymphatic Filariasis in Papua New Guinea

被引:9
作者
Tisch, Daniel J. [1 ]
Alexander, Neal D. E. [2 ,3 ]
Kiniboro, Benson [2 ]
Dagoro, Henry [2 ]
Siba, Peter M. [2 ]
Bockarie, Moses J. [2 ,4 ]
Alpers, Michael P. [2 ,5 ]
Kazura, James W. [1 ]
机构
[1] Case Western Reserve Univ, Cleveland, OH 44106 USA
[2] Papua New Guinea Inst Med Res, Goroka, Papua N Guinea
[3] London Sch Hyg & Trop Med, London WC1, England
[4] Univ Liverpool, Liverpool Sch Trop Med, Liverpool L3 5QA, Merseyside, England
[5] Curtin Univ, Perth, WA, Australia
来源
PLOS NEGLECTED TROPICAL DISEASES | 2011年 / 5卷 / 07期
关键词
PREVENTING ACUTE ADENOLYMPHANGITIS; BANCROFTIAN FILARIASIS; GLOBAL PROGRAM; LYMPHEDEMA MANAGEMENT; AFFECTED-LIMB; ACUTE ATTACKS; DIETHYLCARBAMAZINE; EFFICACY; AREA; PATHOGENESIS;
D O I
10.1371/journal.pntd.0001241
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Background: Acute painful swelling of the extremities and scrotum are debilitating clinical manifestations of Wuchereria bancrofti infection. The ongoing global program to eliminate filariasis using mass drug administration is expected to decrease this and other forms of filarial morbidity in the future by preventing establishment of new infections as a consequence of eliminating transmission by the mosquito vector. We examined whether mass treatment with anti-filarial drugs has a more immediate health benefit by monitoring acute filariasis morbidity in Papua New Guinean communities that participated in a 5-year mass drug administration trial. Methodology/Principal Findings: Weekly active surveillance for acute filariasis morbidity defined by painful swelling of the extremities, scrotum and breast was performed 1 year before and each year after 4 annual mass administrations of anti-filarial drugs (16,480 person-years of observation). Acute morbidity events lasted <3 weeks in 92% of affected individuals and primarily involved the leg (74-79% of all annual events). The incidence for all communities considered together decreased from 0.39 per person-year in the pre-treatment year to 0.31, 0.15, 0.19 and 0.20 after each of 4 annual treatments (p<0.0001). Residents of communities with high pre-treatment transmission intensities (224-742 infective bites/person/year) experienced a greater reduction in acute morbidity (0.62 episodes per person-year pre-treatment vs. 0.30 in the 4(th) post-treatment year) than residents of communities with moderate pre-treatment transmission intensities (24-167 infective bites/person/year; 0.28 episodes per person-year pre-treatment vs. 0.16 in the 4(th) post-treatment year). Conclusions: Mass administration of anti-filarial drugs results in immediate health benefit by decreasing the incidence of acute attacks of leg and arm swelling in people with pre-existing infection. Reduction in acute filariasis morbidity parallels decreased transmission intensity, suggesting that continuing exposure to infective mosquitoes is involved in the pathogenesis of acute filariasis morbidity.
引用
收藏
页数:9
相关论文
共 40 条
  • [1] Addiss David G, 2007, Filaria J, V6, P2, DOI 10.1186/1475-2883-6-2
  • [2] Feasibility and Effectiveness of Basic Lymphedema Management in Leogane, Haiti, an Area Endemic for Bancroftian Filariasis
    Addiss, David G.
    Louis-Charles, Jacky
    Roberts, Jacquelin
    LeConte, Frederic
    Wendt, Joyanna M.
    Milord, Marie Denise
    Lammie, Patrick J.
    Dreyer, Gerusa
    [J]. PLOS NEGLECTED TROPICAL DISEASES, 2010, 4 (04):
  • [3] Absence of ivermectin-associated excess deaths
    Alexander, NDE
    Bockarie, MJ
    Kastens, WA
    Kazura, JW
    Alpers, MP
    [J]. TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE, 1998, 92 (03) : 342 - 342
  • [4] Acute disease episodes in a Wuchereria bancrofti-endemic area of Papua New Guinea
    Alexander, NDE
    Perry, RT
    Dimber, ZB
    Hyun, PJ
    Alpers, MP
    Kazura, JW
    [J]. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 1999, 61 (02) : 319 - 324
  • [5] [Anonymous], 1984, World Health Organ Tech Rep Ser, V702, P3
  • [6] Epidemiology of episodic adenolymphangitis: a longitudinal prospective surveillance among a rural community endemic for bancroftian filariasis in coastal Orissa, India
    Babu, BV
    Nayak, AN
    Dhal, K
    [J]. BMC PUBLIC HEALTH, 2005, 5
  • [7] Lymphangiogenesis and Lymphatic Remodeling Induced by Filarial Parasites: Implications for Pathogenesis
    Bennuru, Sasisekhar
    Nutman, Thomas B.
    [J]. PLOS PATHOGENS, 2009, 5 (12)
  • [8] Randomised community-based trial of annual single-dose diethylcarbamazine with or without ivermectin against Wuchereria bancrofti infection in human beings and mosquitoes
    Bockarie, MJ
    Alexander, NDE
    Hyun, P
    Dimber, Z
    Bockarie, F
    Ibam, E
    Alpers, MP
    Kazura, JW
    [J]. LANCET, 1998, 351 (9097) : 162 - 168
  • [9] Mass treatment to eliminate filariasis in Papua New Guinea
    Bockarie, MJ
    Tisch, DJ
    Kastens, W
    Alexander, NDE
    Dimber, Z
    Bockarie, F
    Ibam, E
    Alpers, MP
    Kazura, JW
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2002, 347 (23) : 1841 - 1848
  • [10] Transmission dynamics of Wuchereria bancrofti in East Sepik Province, Papua New Guinea
    Brockarie, M
    Kazura, J
    Alexander, N
    Dagoro, H
    Bockarie, F
    Perry, R
    Alpers, M
    [J]. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 1996, 54 (06) : 577 - 581